RGEN

REPLIGEN CORP

Healthcare | Mid Cap

$0.44

EPS Forecast

$178.4

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-09-30
CRSPCrispr Therapeutics AgHALOHalozyme Therapeutics IncNBIXNeurocrine Biosciences IncIOVAIovance Biotherapeutics IncREPLReplimune Group IncDNLIDenali Therapeutics IncNVAXNovavax IncTECHBio-techne CorpMRNAModerna Inc